ADVERTISEMENT

OT: Stock and Investment Talk

Sounds like PE is the more likely partner for Disney than any of big tech.

From the article:

I spoke to a half-dozen high-ranking media executives to see if I could find a consensus on the type of company that would do this deal. Several of these execs are familiar with Iger’s thinking.

■ The most popular answer centered on private equity investors like KKR, Apollo or Candle Media, the Blackstone-backed media company run by former Disney executives Kevin Mayerand Tom Staggs.

By going the private equity route, Iger would have cover to manage the business more aggressively and move more quickly into sports gaming and streaming.

This would let Iger take ESPN’s financials — which are likely to be hampered by the continued shrinking of the cable bundle — off Disney’s balance sheet, while also allowing him to keep his hand in the sports business.

Interesting stuff, makes sense, especially getting Staggs and Mayer back in the fold. I'm thinking about doing DIS for my first call option play. Small bet that they right the ship within the next 2 years. $150 strike, hoping DIS gets back to an ATH of $200.
 
F definitely S the bed today:


And so did AT&T and Verizon:

NEW YORK (Reuters) -Shares of AT&T Inc ( T ) fell nearly 7% to hit their lowest level in thirty years on Monday, after analysts downgraded the stock following a news report that the telecommunications giant left toxic lead cables buried across the U.S.

A Wall Street Journal report on July 9 named AT&T ( T ) and Verizon among several telecom giants that abandoned a sprawling network of underground toxic lead cables, with a huge number of them possibly contaminating neighboring soil and drinking water sources.

Analysts at Citigroup and JPMorgan both lowered their recommendations on AT&T ( T ) shares in recent days. The stock has lost a quarter of its value so far this year, having dropped more than 12% since the Wall Street Journal report. The shares hit a low of $13.68 in Monday's session, the lowest since March 1993.

AT&T ( T ) faces unquantifiable financial risks that would create a "long term overhang" for the stock since the company probably has a significant exposure to the toxic lead cables with its network reaching about 40% of homes in the U.S., Citi analysts, led by Michael Rollins, said in an investor note.

Rollins cut his rating on AT&T's ( T ) stock to "neutral" from "buy" and slashed his price target to $16 from $22.

AT&T ( T ) did not immediately respond to a Reuters request for comment. U.S. Telecom, a lobby group representing AT&T ( T ), Verizon and other telecoms firms, said many considerations are made in deciding whether cables are removed or left buried and there's no evidence showing "legacy lead-sheathed telecoms cables" are the "leading cause of lead exposure or the cause of a public health issue."

"We have not seen, nor have regulators identified, evidence that legacy lead-sheathed telecom cables are a leading cause of lead exposure or the cause of a public health issue," a U.S. Telecoms spokesperson said in a statement.

JPMorgan analysts led by Philip Cusick on Friday downgraded their rating on AT&T ( T ) to "neutral" from "overweight," citing worries over the repeated downward revisions for the company's key wireless and fiber growth businesses, the high interest rate environment, and new uncertainty over lead-sheathed cables.

"We have discussed the copper lead sheathing situation with many industry contacts and have been unable to find a reasonable way to calculate any potential liability, but believe that AT&T ( T ) will have the largest exposure given its massive LEC [local exchange carrier] business as well as owning the original AT&T ( T ) long haul network," JPMorgan wrote.

AT&T's ( T ) forward price-to-earnings ratio of 5.95 is less than the industry median of 8.78, according to Eikon data.

Shares of Verizon were also down on Monday, falling 5.5% to $32.14, a nearly 13-year low. Verizon's stock has lost more than 10% since the Wall Street Journal report.

Morningstar analyst Michael Hodel said Friday that while "this situation warrants watching, we don't expect the telecom industry will bear substantial legal liability."
 
Yeah, UNH has a lot of room to run/rally, especially after a clean double beat on earnings. Hope so, it has been holding down the HC index for quite a while.
UNH up 10 today to 495, brought back shares the last couple days knowing it was too early to sell, including the shares I trade for my mom acct, now over 400 shares. Several analysts increased to overweight.


We are upgrading UNH to Outperform on attractive valuation, potential for hardening pricing in 2024, and attractive LT growth in value based care, government MCO and OptumInsights," analysts commented.

The firm set a new $603 price target (up from $595), suggesting a 25% upside from current levels.

Last year, the firm downgraded UNH due to concerns regarding its valuation (1.3x compared to the current 0.9x), anticipating increased utilization in 2023, and apprehensions about MA rate pressures. They felt that these factors were not adequately accounted for in the stock price. Presently, they believe that the majority of these concerns have been factored into the stock price, and the current valuation fails to recognize the long-term growth prospects of UNH's businesses, undervaluing them.

Considering the YTD decline of approximately 9% in the stock and the valuation dropping to 0.9x of SPX, they are of the opinion that the majority of concerns regarding medical costs have been factored into the price. UNH, in their view, stands out as a superior Managed Care Organization (MCO) and Value-Based Care (VBC) company. Furthermore, they see the current valuation presents an exceptional chance to acquire a stake in a business with significant growth potential ahead, all at an appealing valuation.
 
Last edited:
  • Like
Reactions: T2Kplus20
UNH up 10 today to 495, brought back shares the last couple days knowing it was too early to sell, including the shares I trade for my mom acct, now over 400 shares. Several analysts increased to overweight.


We are upgrading UNH to Outperform on attractive valuation, potential for hardening pricing in 2024, and attractive LT growth in value based care, government MCO and OptumInsights," analysts commented.

The firm set a new $603 price target (up from $595), suggesting a 25% upside from current levels.

Last year, the firm downgraded UNH due to concerns regarding its valuation (1.3x compared to the current 0.9x), anticipating increased utilization in 2023, and apprehensions about MA rate pressures. They felt that these factors were not adequately accounted for in the stock price. Presently, they believe that the majority of these concerns have been factored into the stock price, and the current valuation fails to recognize the long-term growth prospects of UNH's businesses, undervaluing them.

Considering the YTD decline of approximately 9% in the stock and the valuation dropping to 0.9x of SPX, they are of the opinion that the majority of concerns regarding medical costs have been factored into the price. UNH, in their view, stands out as a superior Managed Care Organization (MCO) and Value-Based Care (VBC) company. Furthermore, they see the current valuation presents an exceptional chance to acquire a stake in a business with significant growth potential ahead, all at an appealing valuation.
UNH rallying bodes well for the entire HC sector, which has lagged all year. I own a ton of UNH via PRHSX, CURE, and VTV/VVIAX. Increased medical activity is GOOD for payers and insurance companies (and yes, UNH even has a provider network). This brings in more revenue. Sure, payout and coverage costs increase as well, but it is still profitable growth.

Speaking of which, we are meeting with UNH on one of our upcoming gene therapy products next week. They are an important customer of ours. :)
 
  • Like
Reactions: RU in IM
MSFT on fire. Several announcements made recently regarding AI and other partnerships. Aggressive in the PR world right now for sure. Hodling for now for sure. Price targets are 400 ish.
 
MSFT on fire. Several announcements made recently regarding AI and other partnerships. Aggressive in the PR world right now for sure. Hodling for now for sure. Price targets are 400 ish.
Nice, sold some today but still keeping some for LT.

Others that are in my portfolio are ADP and PRU that are moving.
 
MSFT on fire. Several announcements made recently regarding AI and other partnerships. Aggressive in the PR world right now for sure. Hodling for now for sure. Price targets are 400 ish.
Just saw it’s having a Nvidia like pump today. MSFT along with XOM were my two best pickups during March of 2020. DIS not so much. Can’t win them all. Been DCA into VOO the last few months. All long term holds for me.
 
UNH up 10 today to 495, brought back shares the last couple days knowing it was too early to sell, including the shares I trade for my mom acct, now over 400 shares. Several analysts increased to overweight.


We are upgrading UNH to Outperform on attractive valuation, potential for hardening pricing in 2024, and attractive LT growth in value based care, government MCO and OptumInsights," analysts commented.

The firm set a new $603 price target (up from $595), suggesting a 25% upside from current levels.

Last year, the firm downgraded UNH due to concerns regarding its valuation (1.3x compared to the current 0.9x), anticipating increased utilization in 2023, and apprehensions about MA rate pressures. They felt that these factors were not adequately accounted for in the stock price. Presently, they believe that the majority of these concerns have been factored into the stock price, and the current valuation fails to recognize the long-term growth prospects of UNH's businesses, undervaluing them.

Considering the YTD decline of approximately 9% in the stock and the valuation dropping to 0.9x of SPX, they are of the opinion that the majority of concerns regarding medical costs have been factored into the price. UNH, in their view, stands out as a superior Managed Care Organization (MCO) and Value-Based Care (VBC) company. Furthermore, they see the current valuation presents an exceptional chance to acquire a stake in a business with significant growth potential ahead, all at an appealing valuation.
This is actually an area I targeted to trim some if I had gotten in. I think this low 500s (up to 515-520) area could have some resistance but we'll see.
 
This is actually an area I targeted to trim some if I had gotten in. I think this low 500s (up to 515-520) area could have some resistance but we'll see.
It reached $500 in three days, a nice $20,000 gain. I expect it to reach the old 52 week high of $558 at some point. The stock will continue to go up for the earning season but it might take some time to reach it but $520 is a given. Hope to make the other $50 point gain.

I made the 50 point gain last quarter in a week. At some point it will retreat and will be available at $460-470 which is a great point to buy. Another stock that I’m been buying and selling every quarter is BDX, if you look at the charts it go down 10-20% every quarter and go back close to the 52 week high. I just got to remember to buy a large enough quantity to give me a sizable gain.

I use to do this with Amazon, Facebook and PayPal the last couple of years, buy and sell.
 
Last edited:
  • Like
Reactions: T2Kplus20
It reached $500 in three days, a nice $20,000 gain. I expect it to reach the old 52 week high of $558 at some point. The stock will continue to go up for the earning season but it might take some time to reach it but $520 is a given. Hope to make the other $50 point gain.

I made the 50 point gain last quarter in a week. At some point it will retreat and will be available at $460-470 which is a great point to buy. Another stock that I’m been buying and selling every quarter is BDX, if you look at the charts it go down 10-20% every quarter and go back close to the 52 week high. I just got to remember to buy a large enough quantity to give me a sizable gain.

I use to do this with Amazon, Facebook and PayPal the last couple of years, buy and sell.
Looking at BDX I'd say it looks range bound the last 5 years or so. 220s on the low end and 250s on the high end. It's near the high end of the range currently.
 
Looking at BDX I'd say it looks range bound the last 5 years or so. 220s on the low end and 250s on the high end. It's near the high end of the range currently.
I sold all of my BDX recently, BDX reached 260 the last 4 qtrs. $264 on 6/30/23. Yes, it’s range bound but that’s why you can buy low and sell high. BDX went up 8 times in the last 20 years.
 
Last edited:
I sold all of my BDX recently. Yes, it’s range bound but that’s why you can buy low and sell high.
Of course if it stays in the range, or goes higher for that matter, thats just fine. I actually put an alert for me to take a look again if it hits a price target.
 
It reached $500 in three days, a nice $20,000 gain. I expect it to reach the old 52 week high of $558 at some point. The stock will continue to go up for the earning season but it might take some time to reach it but $520 is a given. Hope to make the other $50 point gain.

I made the 50 point gain last quarter in a week. At some point it will retreat and will be available at $460-470 which is a great point to buy. Another stock that I’m been buying and selling every quarter is BDX, if you look at the charts it go down 10-20% every quarter and go back close to the 52 week high. I just got to remember to buy a large enough quantity to give me a sizable gain.

I use to do this with Amazon, Facebook and PayPal the last couple of years, buy and sell.
Agreed. UNH going back to ATHs. The entire sector is primed for a big catch-up rally. As growth and tech have boomed this year. I have been adding a ton of new money to HC and value to maintain allocations.
 
I sold all of my BDX recently, BDX reached 260 the last 4 qtrs. $264 on 6/30/23. Yes, it’s range bound but that’s why you can buy low and sell high. BDX went up 8 times in the last 20 years.
BDX is a slow growth medical device company. I'm not surprised is has been oscillating for the past 5 years or so. You can try a call option if you want to maximize the movement.
 
@RU-05
FYI - Guy and Dan got absolutely blasted on Fast Money by the host (forgot her name). Accused of being too bearish and living in a bearish eco-chamber. She even mentioned their podcast where they talk about being bearish with each other. Freaking priceless. I heard it on XM on the way home from work. I'm sure the visual was funny as hell.
 
  • Like
Reactions: RU-05
Looking at BDX I'd say it looks range bound the last 5 years or so. 220s on the low end and 250s on the high end. It's near the high end of the range currently.
Hilariously range bound over the last 5 years. But when you zoom out, the all time chart looks really good and this 5 year span could be providing a solid base for the stock to take off from.
 
Of course if it stays in the range, or goes higher for that matter, thats just fine. I actually put an alert for me to take a look again if it hits a price target.
Alert at the low end? or an alert for a break out of the high end?
 
Nice, sold some today but still keeping some for LT.

Others that are in my portfolio are ADP and PRU that are moving.
PRU was one of the first stocks I bought post Covid, did very well with it early, but it's been a dud since early 2022, the last 6 weeks it's maybe gotten back on it's horse. Fingers crossed.

5.4% div
 
Alert at the low end? or an alert for a break out of the high end?
Low end, I’m not one who acts on breakouts and confirmation too often. My conservative nature always makes me hesitant of false breakouts.

You could use a stop to limit downside but if I used a stop I’d be more inclined to use it when it’s at a low support and if it breaks it somewhat then I’d be out.

For what I consider quality companies, I’m less inclined to use stops and instead just accumulate. But for a company, say like MMM recently that has massive headline and liability risk I’d be inclined to use it if I got in, even though I think it’s a quality company.
 
  • Like
Reactions: RU-05
Hilariously range bound over the last 5 years. But when you zoom out, the all time chart looks really good and this 5 year span could be providing a solid base for the stock to take off from.
My brother and his wife worked there about 40 years ago and when I look back it was about $2 a share and now $256. I don’t know how that compares with AAPL but it’s dam good. He worked there 25 years and stock options were great. It tends to pop every 5-10 years.
 
Last edited:
  • Like
Reactions: T2Kplus20
Low end, I’m not one who acts on breakouts and confirmation too often. My conservative nature always makes me hesitant of false breakouts.

You could use a stop to limit downside but if I used a stop I’d be more inclined to use it when it’s at a low support and if it breaks it somewhat then I’d be out.

For what I consider quality companies, I’m less inclined to use stops and instead just accumulate. But for a company, say like MMM recently that has massive headline and liability risk I’d be inclined to use it if I got in, even though I think it’s a quality company.
Same here. I buy high quality stocks when they get close to 52 week low and sell close to their high but sometimes I will jump aboard stocks that continue to go up without any retracement. This method is very conservative even though I trade a lot but allows me to be in more cash instead of being in the market all the time. This also allowed me to out of the market when the markets have crashed. I also believe in the buy and hold but it’s just not as fun, something to do in retirement about 1 hour a day.

There plenty of ways to make money in the market.
 
Last edited:
My brother and his wife worked there about 40 years ago and when I look back it was about $2 a share and now $256. I don’t know how that compares with AAPL but it’s dam good. He worked there 25 years and stock options were great. It tends to pop every 5-10 years.
It's a pimple on AAPL's buttocks.

It's been good though.
 
@RU-05
FYI - Guy and Dan got absolutely blasted on Fast Money by the host (forgot her name). Accused of being too bearish and living in a bearish eco-chamber. She even mentioned their podcast where they talk about being bearish with each other. Freaking priceless. I heard it on XM on the way home from work. I'm sure the visual was funny as hell.
I assume it had to be the regular host Melissa Lee, she'd be the only one ballsy enough in that spot to blast them. She also has a great rapport with those guys, especially Guy, so she can blast them with creating serious tension.

She's great though, The Judge is great on the Halftime show, I think Mel is even better on Fast Money. Whenever another host is on in place of those two those shows fall off significantly. Interestingly Mel on the Halftime wasn't good. Her comfort zone is with the Fast Money traders like Guy, Tim, and Karen.

I have yesterdays show on my podcasts, maybe I'll listen to it if I go to the gym today, but if you can find a clip that would be cool.
 
I assume it had to be the regular host Melissa Lee, she'd be the only one ballsy enough in that spot to blast them. She also has a great rapport with those guys, especially Guy, so she can blast them with creating serious tension.

She's great though, The Judge is great on the Halftime show, I think Mel is even better on Fast Money. Whenever another host is on in place of those two those shows fall off significantly. Interestingly Mel on the Halftime wasn't good. Her comfort zone is with the Fast Money traders like Guy, Tim, and Karen.

I have yesterdays show on my podcasts, maybe I'll listen to it if I go to the gym today, but if you can find a clip that would be cool.
Yes, it was definitely Melissa Lee. She was tough, but with a smile, so I assume they knew it was coming.

Just found a clip! Just sent it via conversation/DM thread.
 
Likes financials.

Kind of like his Oil call back in 2021, or better put, because of, when a bullish guy like Lee picks a downtrodden sector, my ears perk.
I was hoping for TL and MN to get bullish on HC, but they started to highlight financials last week (in particular, capital market and banks).

FYI - bought my first call on Monday to test it out. I'm not sure if this is normal, but Fidelity essentially makes it look and feel like a typical holding (stock or ETF). Seems simple to track and manage. Bought DIS 130 for Jan 2025. This is more of a beta for me. May not hold it too long. Up a few bucks as of yesterday. I think LEAP calls are my speed. Just a way to leverage up my buy and hold strategy. I'm not sure of the exact details yet (strike or duration) but I do believe DIS will bottom soon and start to slowly rebound. Iger may throw the kitchen sink of bad news into the early Aug earnings report.
 
I was hoping for TL and MN to get bullish on HC, but they started to highlight financials last week (in particular, capital market and banks).

FYI - bought my first call on Monday to test it out. I'm not sure if this is normal, but Fidelity essentially makes it look and feel like a typical holding (stock or ETF). Seems simple to track and manage. Bought DIS 130 for Jan 2025. This is more of a beta for me. May not hold it too long. Up a few bucks as of yesterday. I think LEAP calls are my speed. Just a way to leverage up my buy and hold strategy. I'm not sure of the exact details yet (strike or duration) but I do believe DIS will bottom soon and start to slowly rebound. Iger may throw the kitchen sink of bad news into the early Aug earnings report.
My E-trade denotes it as a Call or a Put directly under the ticker in my account, so it's pretty clear when it's an option contract.

When I sell options, I get a negative in the qty. But otherwise it looks much like a stock holding.
 
KSS at $25.49.

It's 200DMA at $25.99.

It is above it's 50 day, it broke a downward trendline dating back to it's highs in 2022, and looks like it is past some resistance at the $24-$25 level.

I'm in it, bought it last week, it dipped, but has rebounded, so I'm up a little.

8% div.
 
Sold my ETHE. Small position, was up 16% in a couple weeks.

Just not liking BTC below $30K, feel that will eventually spread to the other crypto's.

I am holding onto GBTC. Again a small position, just slightly in the green, if it was up more I'd sell, if it drops I'll add.

And holding my ATOM coins. Earn's 17% while staking.
 
Last edited:
  • Like
Reactions: T2Kplus20
SOFI at $9.75.

I own it, but I'm short this weeks $10 calls, which I sold back when it was $8 a month or two back.
Going to be a tight one, if it doesn't totally rip past it, I'll prob just buy them back.
 
ADVERTISEMENT
ADVERTISEMENT